International Stem Cell CORP (ISCO) stock

ISCOOTCPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 1/30

$0.28+0.00 (+0.89%)

Close on Oct 19, 2026Market cap $2.27MP/E –Yield –

International Stem Cell price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

International Stem Cell's price to book ratio was 3.3× on Apr 30, 2019, against 4.1× a year earlier. Over the last 5 years it ranged from 0.0× to 129.0×, with a median of 7.1×.

Price to Book Ratio at the end of each year

Period	Period end	Value	Change (pts)
2019	Apr 30, 2019	3.3×	−0.3
2018	Dec 31, 2018	3.6×	−0.6
2017	Oct 31, 2017	4.2×	−4.6
2016	Dec 30, 2016	8.8×	+0.3
2015	Dec 31, 2015	8.5×	−51.7
2013	Jul 31, 2013	60.2×	−15.7
2012	Dec 31, 2012	75.9×	+69.7
2011	Dec 30, 2011	6.2×	–

Where these numbers come from

Parsed from the XBRL in International Stem Cell's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-150 reverse split on Jul 29, 2015
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing